Drugs / Hesperidin+Diosmin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06584799 Comparator | Dec 2024 → Jan 2025 overdue | pelvic congestion syndrome | Pirogov Russian National Research Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hesperidin+Diosmin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06584799 ↗ |
| Known as | HDC | “Methods: VENOTREAT was a single-center, randomized, open-label study included 150 women with symptomatic PeVD, who were allocated for the 2-month therapy a once-daily intake...” PMID 40855727 ↗ Aug 2025 |